NCBC 2024

Annual Interdiciplinary Breast Cancer Conference


Ambry Genetics is a pround sponsor of the 2024 NCBC Annual Meeting and supporter of the NCBC organization. We invite you to visit us at booth 501+505 to learn more about Ambry's CARE program, our risk assessment tool that makes is easy to identify high-risk patients who qualify for hereditary cancer testing. Ambry offers paired DNA and RNA testing that helps identify more cases of hereditary cancer and fewer variants of uncertain significance (VUS). 

Click HERE to learn more about Ambry's hereditary cancer testing or any of our other test offerings.

 

Research

Contact an Author

Scientific Posters

Poster # tbd

Friday, March 15, 2024 12:00 - 12:00pm Abstract Poster

Heather Fecteau, Haley Keller, Meagan Farmer, Carrie Horton, Shannon Kieran. Use of a patient-facing digital platform to aid in genetic test result delivery and connection to genetic counseling services.

Get in Touch With Us

Contact a Sales Rep

Our Blog

Read our blog on why Ambry is using evidence-based quality testing.

Read More

Search Results

Start your search...